Advertisement

Oxaliplatin-Induced Multiple Focal Nodular Hyperplasia Masquerading as Colorectal Liver Metastasis—Case Report and Review of Literature

  • Chirag Jain
  • Asif Syed
  • Nikhil Gupta
  • Meenakshi Kambhoj
  • Avinash Rao
  • Shivendra SinghEmail author
Case Report
  • 11 Downloads

Introduction

Focal nodular hyperplasia (FNH) is a benign condition with the prevalence of around 2.6% in autopsy studies [1, 2]. Pathophysiology of FNH is poorly understood with intrahepatic blood flow distortion being one of the most plausible theories [3].

Oxaliplatin causes vascular injury in the form of sinusoidal dilatation with erythrocyte extravasation leading to sinusoidal obstruction syndrome (SOS) or blue liver. Extreme form of vascular injury leads to regenerative nodular hyperplasia also known as FNH.

SOS usually presents as reticular hyperintensity on hepatobiliary phase of gadoxetic acid–enhanced magnetic resonance images (EOB-MRI), but does not usually present with focal lesions [4]. Very few case reports are there in literature where patients have presented with liver lesion post oxaliplatin-based chemotherapy. We present a case of a rectal cancer patient who after surgery and oxaliplatin-based chemotherapy presented with liver lesions masquerading as liver metastasis.

Case...

Notes

Author’s Contribution

Chirag Jain prepared the first draft of the paper.

Asif Syed collected all the images and follow up of the patient for compiling the manuscript.

Nikhil Gupta contributed in the clinical management of the patient and also in correcting the draft of the manuscript.

Meenakshi Kambhoj prepared the pathology manuscript of the patient in the study.

Avinash Rao finalized the radiological findings and contributed significantly in the preparation of the manuscript.

Shivendra Singh finalized the manuscript and contributed significantly in editing the manuscript.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that there are no conflicts of interest.

References

  1. 1.
    Nakanuma Y. Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J Clin Gastroenterol. 1990;12:460–5.CrossRefGoogle Scholar
  2. 2.
    Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology. 1990;11:787–97.CrossRefGoogle Scholar
  3. 3.
    Rubbia-Brandt L, Lauwers GY, Wang H, Majno PE, Tanabe K, Zhu AX, et al. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology. 2010;56:430–9.CrossRefGoogle Scholar
  4. 4.
    Shin NY, Kim MJ, Lim JS, Park MS, Chung YE, Choi JY, et al. Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases. Eur Radiol. 2012;22:864–71.CrossRefGoogle Scholar
  5. 5.
    Bioulac-Sage P, Laumonier H, Cubel G, Rossi JZ, Balabaud C. Hepatic resection for inflammatory hepatocellular adenomas: pathological identification of micronodules expressing inflammatory proteins. Liver Int. 2010;30:149–54.CrossRefGoogle Scholar
  6. 6.
    Hubert C, Sempoux C, Horsmans Y, Rahier J, Humblet Y, Machiels JP, et al. Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases? Liver Int. 2007;27:938–43.CrossRefGoogle Scholar
  7. 7.
    Komori H, Beppu T, Baba Y, Horino K, Imsung C, Masuda T, et al. Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients. Int J Clin Oncol. 2010 Jun;15(3):263–70.CrossRefGoogle Scholar
  8. 8.
    Wicherts DA, de Haas RJ, Sebagh M, Ciacio O, Lévi F, Paule B, et al. Regenerative nodular hyperplasia of the liver related to chemotherapy: impact on outcome of liver surgery for colorectal metastases. Ann Surg Oncol. 2011;18:659–69.CrossRefGoogle Scholar
  9. 9.
    Ribero D, Wang H, Donadon M, Zorzi D, Thomas MB, Eng C, et al. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin based chemotherapy for colorectal liver metastases. Cancer. 2007;110:2761–7.CrossRefGoogle Scholar
  10. 10.
    Donadon M, Di Tommaso L, Roncalli M, Torzilli G. Multiple focal nodular hyperplasias induced by oxaliplatin-based chemotherapy. World J Hepatol. 2013;5(6):340–4.CrossRefGoogle Scholar
  11. 11.
    Choi JH, Won YW, Kim HS, Oh YH, Lim S, Kim HJ. Oxaliplatin-induced sinusoidal obstruction syndrome mimicking metastatic colon cancer in the liver. Oncol Lett. 2016;11(4):2861–4.CrossRefGoogle Scholar
  12. 12.
    Arakawa Y, Shimada M, Utsunomya T, Imura S, Morine Y, Ikemoto T, et al. Oxaliplatin-related sinusoidal obstruction syndrome mimicking metastatic liver tumors. Hepatol Res. 2013;43(6):685–9.CrossRefGoogle Scholar
  13. 13.
    Uchino K, Fujisawa M, Watanabe T, Endo Y, Nobuhisa T, Matsumoto Y, et al. Oxaliplatin-induced liver injury mimicking metastatic tumor on images: a case report. Jpn J Clin Oncol. 2013;43(10):1034–8.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Chirag Jain
    • 1
  • Asif Syed
    • 1
  • Nikhil Gupta
    • 1
  • Meenakshi Kambhoj
    • 2
  • Avinash Rao
    • 3
  • Shivendra Singh
    • 1
    Email author
  1. 1.Department of GI OncosurgeryRajiv Gandhi Cancer Institute and Research CenterNew DelhiIndia
  2. 2.Department of PathologyRajiv Gandhi Cancer Institute and Research CenterNew DelhiIndia
  3. 3.Department of RadiodiagnosisRajiv Gandhi Cancer Institute and Research CenterNew DelhiIndia

Personalised recommendations